🔎How are we redefining #highriskmyeloma—and what does this mean for treatment? #MultipleMyelomaAwarenessMonth🩸

Dr Karthik Ramasamy discusses key mutational changes in #TP53 & #biallelicalterations and why they're critical to understanding high-risk disease

👉 buff.ly/3EJQyxN